Trials / Sponsors / Triumvira Immunologics, Inc.
Triumvira Immunologics, Inc.
Industry · 3 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Active Not Recruiting | TAC T-cells for the Treatment of Claudin 18.2 Positive Solid Tumors (TACTIC-3) Metastatic Solid Tumor | Phase 1 / Phase 2 | 2023-08-23 |
| Terminated | TAC T-cells for the Treatment of HER2-positive Solid Tumors HER2 Positive Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer | Phase 1 / Phase 2 | 2021-04-19 |
| Withdrawn | Autologous TAC T Cells Targeting CD19 in R/R Large B-Cell Lymphoma Lymphoma, B-Cell | Phase 1 / Phase 2 | 2020-05-01 |